Both in Surgical Instruments
Femasys vs Cytosorbents
Over the past year FEMY returned −89.7% and CTSO returned −72.7%; their daily moves had a correlation of 0.02.
FEMY −89.7% CTSO −72.7%Growth of $1, one year, split-adjusted
| Metric | FEMY | CTSO |
|---|---|---|
| Price | $1.36 | $4.26 |
| Market cap | $11.4M | $13.4M |
| Today | +3.03% | +3.32% |
| 1 month | −32.7% | +7.4% |
| 6 months | −83.0% | −64.8% |
| Year to date | −88.2% | −66.7% |
| 1 year | −89.3% | −73.2% |
| Revenue growth (YoY) | −18.9% | +0.2% |
| Gross margin | 57.1% | 73.2% |
| Net margin | −1346.8% | −45.9% |
| P/E (TTM) | — | — |
| Price / sales | 5.0× | 0.4× |
| Net cash | -$2.1M | -$12.8M |
| Dividend yield | — | — |
| Volatility (60d) | 90.2% | 881.2% |
| Short % of float | 2.4% | 0.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).